Aegon Ltd.
Aegon Ltd. (AEG) Financial Performance & Income Statement Overview
Analyze Aegon Ltd. (AEG) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Aegon Ltd. (AEG) Income Statement & Financial Overview
Analyze Aegon Ltd.’s AEG earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $16.29B | $3.23B | $3.23B | $3.11B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $16.29B | $3.23B | $3.23B | $3.11B |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.83B | $153.00M | $153.00M | $157.50M |
| Operating Expenses | $18.71B | $153.00M | $153.00M | $3.10B |
| Total Costs & Expenses | $18.71B | $153.00M | $153.00M | $3.10B |
| Interest Income | $5.80B | $0.00 | $0.00 | $112.00M |
| Interest Expense | $6.00M | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | -$107.50M | $76.50M | $0.00 | $92.50M |
| EBITDA | -$5.59B | $6.22B | $3.15B | $129.00M |
| EBITDA Ratio | -$0.34 | $1.93 | $0.98 | $0.04 |
| Operating Income | -$2.42B | $3.07B | $3.07B | -$92.50M |
| Operating Income Ratio | -$0.15 | $0.95 | $0.95 | -$0.03 |
| Other Income/Expenses (Net) | $3.14B | -$3.14B | -$3.14B | -$10.00M |
| Income Before Tax | $727.50M | -$67.50M | -$67.50M | -$102.50M |
| Income Before Tax Ratio | $0.04 | -$0.02 | -$0.02 | -$0.03 |
| Income Tax Expense | -$51.00M | $35.00M | $35.00M | $70.00M |
| Net Income | $714.00M | -$26.00M | -$26.00M | -$33.50M |
| Net Income Ratio | $0.04 | -$0.008 | -$0.008 | -$0.01 |
| EPS | $0.42 | -$0.05 | -$0.03 | -$0.02 |
| Diluted EPS | $0.33 | -$0.03 | -$0.02 | -$0.02 |
| Weighted Avg Shares Outstanding | $2.01B | $1.67B | $1.67B | $1.84B |
| Weighted Avg Shares Outstanding (Diluted) | $2.01B | $1.67B | $1.67B | $1.84B |
The company's financials show resilient growth, with revenue advancing from $3.11B in Q4 2023 to $16.29B in Q4 2024. Gross profit remained healthy with margins at 100% in Q4 2024 compared to 100% in Q4 2023. Operating income hit -$2.42B last quarter, sustaining a consistent -15% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$5.59B. Net income rose to $714.00M, while earnings per share reached $0.42. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan